Read the original post: Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
Read the original post: Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics
View post: Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules
Continue reading here: Epitopea and Genevant Sciences Announce Collaboration Agreement
Here is the original post: Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma
Go here to read the rest: ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies
Read the rest here: Idorsia provides update on the exclusive negotiations for the global rights to aprocitentan
See the article here: Santhera Announces Approval in Hong Kong for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
See original here: Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Read this article: CancerVax Passes First Test with Flying Colors
Read more: Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Recent Comments